Metadyne

Quick links to important sections

Metadyne

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metadyne

Property Description
Active Ingredient Povidone-Iodine (PVP-I)
Form Solution, Ointment, Surgical Scrub (Topical)
Pharmacological Class Antiseptic, Germicide, Iodophor
General Purpose Skin disinfection, Infection prevention
Origin Synthetic (Povidone component)

Metadyne is a pharmaceutical preparation utilizing the active complex Povidone-Iodine (PVP-I), which is classified as an Anti-Infective Agent, Local. This chemical classification places Metadyne within the iodophor class, signifying a compound that gradually releases iodine to function as a powerful, broad-spectrum antiseptic and germicide on external surfaces. The compound’s fundamental importance is underscored by its inclusion on the World Health Organization's List of Essential Medicines, a designation that reflects its globally recognized essential status for infection control.

Composition and Available Preparations

The composition of Metadyne is based on the chemical complex of elemental Iodine and the synthetic polymer Povidone (polyvinylpyrrolidone, PVP). This unique binding mechanism, where Povidone serves as a stabilizing, water-soluble carrier, ensures that the microbicidal Iodine is slowly liberated upon application. This controlled release maintains the necessary active concentration over time, and is clinically recognized for improved local tolerability compared to simple iodine tinctures. Depending on the external use, Metadyne is available in various topical forms, including aqueous solution, dermal ointment, and specialized surgical scrub preparations, all designed for non-systemic application.

General Function and Benefit as an Antiseptic

The primary function of Metadyne is to achieve reliable infection control by causing the rapid destruction of a broad spectrum of microorganisms, encompassing bacteria, viruses, and fungi, on the exterior body surfaces. This comprehensive germicidal action is achieved through oxidation, where the released Iodine chemically alters critical proteins and fatty acids within microbial cells, causing their destruction. This functional property makes Metadyne generally useful for common scenarios such as disinfecting skin before a minor procedure or applying to clean cuts and abrasions, supporting wound care and providing robust external pathogen clearance.

Regulatory References

  1. WHO Essential Medicines List for Povidone-Iodine

What side effects are possible with Metadyne?

Possible Side Effects and Safety Information

Metadyne (Povidone-Iodine) safety information, as documented in official government regulatory documents, focuses on both local reactions at the site of application and the potential for systemic effects related to iodine absorption.

Adverse Reaction Scope

The frequency classification for many adverse reactions, especially serious ones, is officially listed as Not known (meaning the incidence cannot be reliably estimated from available regulatory data).

System-Organ Class Officially Documented Reactions
Skin and Subcutaneous Tissue Local irritation, redness, and contact dermatitis (symptoms include erythema, itching, and blistering). Reversible, transient brown coloration of the skin.
Immune System Disorders Serious hypersensitivity reactions, including generalized anaphylactic reactions and anaphylactic shock.
Endocrine Disorders Abnormal thyroid function, including hypothyroidism, due to systemic iodine absorption.

Serious Safety Considerations

The most serious documented safety concerns relate to the immune system and the endocrine system. Anaphylactic shock represents a rare but severe systemic reaction. The risk of abnormal thyroid function is specifically associated with regular and prolonged application or extensive use, which leads to toxic levels of iodine accumulation.

Population-Specific Constraints

Official labeling includes specific restrictions for certain patient populations:

  • Neonates and Pre-term Infants: Use is often contraindicated in pre-term infants and neonates (up to one month of age) due to the heightened risk of developing abnormal thyroid function.
  • Thyroid Dysfunction: Patients with pre-existing thyroid conditions, such as hyperthyroidism, require caution, as extensive iodine absorption may exacerbate the condition.
  • Pregnancy/Lactation: Use should be kept to the minimum necessary, as absorbed iodine may affect the fetal or neonatal thyroid.

Additionally, Metadyne is contraindicated in patients with a known hypersensitivity to the components and with the concomitant use of mercury-based derivatives.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Metadyne (Povidone-Iodine) describes overdose as potentially resulting from accidental ingestion or excessive systemic absorption over a prolonged period. Immediate action is required upon any suspicion of overdose.

Manifestations & Outcomes Regulatory Description
Systemic Manifestations Symptoms may include fever, metallic taste, decreased level of alertness (stupor), delirium, and severe gastrointestinal effects such as vomiting, diarrhoea, and mouth burning.
Severe Outcomes Overdose is documented to lead to life-threatening conditions, including circulatory collapse, acute renal failure, and serious metabolic acidosis. Laryngeal or pulmonary edema may also occur.

When to Seek Urgent Medical Help

Regulatory guidance explicitly states that a suspected overdose mandates seeking immediate medical help or contacting a Poison Control Center or emergency department at once.

Official Management and Monitoring

No specific antidote is known for iodine toxicity; therefore, treatment is entirely symptomatic and supportive. Management requires close monitoring of vital signs, electrolyte balance, and liver function. Furthermore, continuous monitoring of renal function and thyroid function is mandated due to the substance’s known physiological effects.

Population Considerations

The labeling notes a heightened risk of toxicity in patients with impaired renal function, who require close monitoring of blood iodine levels. Additionally, neonates and small infants are at an increased risk of developing hypothyroidism following exposure to large amounts of iodine, requiring specific thyroid function monitoring.

Therapeutic Uses of Metadyne

What Metadyne Treats: Main Uses and Benefits

Metadyne is commonly used across therapeutic domains involving external microbial threats, generally applied in settings where short-term symptomatic assistance is needed.

Metadyne is used for managing microbial contamination by providing broad-spectrum clearance of external pathogens, and provides supportive relief when symptoms interfere with routine activities during periods of acute external trauma. It is considered relevant for a range of conditions, including first-aid antisepsis for minor cuts and scrapes, pre-operative skin preparation before procedures, and the supportive management of bioburden in chronic skin ulcers.


Core Therapeutic Focus

The product is relevant across therapeutic contexts involving external microbial challenges and is commonly used when short-term symptomatic assistance is needed.

It is applied in addressing groups of symptoms that may become intense or disruptive, such as the symptoms related to inflammatory or irritative states following a dermal breach or the symptoms associated with persistent microbial colonization.

It is also relevant for easing symptomatic manifestations associated with microbial imbalances in specialized areas, like localized throat irritation or vaginal discomfort. It contributes to improved day-to-day comfort and supports general well-being during symptomatic phases.

Quick Fact: Relief for Infection Risk
Metadyne is often used when the risk of localized infection is heightened, providing supportive relief that helps ease the overall symptom burden.

Regulatory References

  1. DailyMed (NIH) Antiseptic Labeling

Eligibility and Restrictions for Use

Official Eligibility and Contraindication Rules

Metadyne's population eligibility profile, as defined by regulatory documents, outlines groups who are strictly prohibited from use and populations for whom use is conditional.

Populations for Whom Use is Contraindicated

Use is strictly contraindicated in individuals with known hypersensitivity to povidone-iodine. It must not be used by patients with overt hyperthyroidism or manifest thyroid diseases, nor by those undergoing radioactive iodine therapy. Use is also prohibited in patients diagnosed with Dermatitis Herpetiformis.

Restricted and Conditional Use

The medicine is not recommended for newborn infants (typically under one month of age). Use in women who are pregnant or breastfeeding must be avoided or strictly minimized due to the risk of iodine transfer causing transient hypothyroidism in the fetus or nursing infant. Application over large body surface areas or for prolonged periods (generally exceeding 14 days) is restricted for all individuals to prevent excessive systemic absorption. Special caution is advised for patients with existing renal insufficiency.

What should I know about interactions with other medicines?

The official regulatory profile for Metadyne, which contains Povidone-Iodine, documents specific interactions based on chemical incompatibility and systemic effects, rather than metabolic pathways.

Contraindicated and Restricted Combinations

Co-administration with mercury derivatives is formally contraindicated, as the combination may lead to the formation of a caustic compound, mercury iodide. The efficacy of Metadyne may be mutually reduced when combined with other topical agents, including hydrogen peroxide, Taurolidine, and silver compounds due to chemical reactions.

There are also restrictions regarding advanced wound care products. Exposure of allogeneic cultured keratinocytes/fibroblasts to this antiseptic is a contraindication that requires a thorough washout period before the advanced product is applied.

Timing and Systemic Considerations

A mandatory timing restriction applies to the use of Metadyne with Octenidine-based antiseptics; these substances must not be used concomitantly or immediately after one another in the same site, as an undesirable local discoloration may occur.

Systemic interactions are noted with Lithium; regular topical application, particularly over extensive body surfaces, should be avoided in patients receiving this medication due to the potential for a synergistic effect on the thyroid gland. Separately, iodine absorption from Metadyne may interfere with thyroid diagnostic tests, such as radioiodine diagnostics, necessitating a waiting period.

Mechanism of Action

How Metadyne Works: Mechanism of Action

Metadyne's core mechanism involves specific agonism at the mu-opioid receptor (mu-OR), a type of G-protein coupled receptor (GPCR) found on nerve cells within the central nervous system (CNS). This interaction directly initiates an inhibitory intracellular cascade. Binding of Metadyne activates the GPCR, leading to the dissociation of the G-protein complex.

This cascade primarily operates by modulating the Descending Inhibitory Pain Pathway (DIPP). The activation suppresses the release of excitatory neurotransmitters (like Substance P and glutamate) and induces neuronal hyperpolarization, which reduces the transmission of nociceptive signals. The result is a physiological state of reduced nociception.

Furthermore, the mu-OR mechanism in autonomic centers of the brainstem causes the inhibition of key neuronal groups. This systemic effect leads to specific physiological consequences, including a decrease in respiratory drive (respiratory depression) and a reduction in intestinal motility (constipation).

Dosage and Administration Information

How to Use Metadyne: Official Administration Guidelines

Metadyne is to be used according to the specific administration instructions outlined in the official regulatory product information. The correct procedural steps, dosage, and timing are key components of the documented regimen.

Administration Details

Instruction Component Official Specification
Route of Administration Oral (by mouth)
Dosing Schedule Once daily in the morning
Starting Dose (Adults/Pediatrics) 20 mg once daily
Maximum Dose 60 mg per day
Timing in Relation to Meals Administer before breakfast
Age-Group Rules Indicated for pediatric patients 6 to 15 years of age

Preparation and Procedural Steps

Metadyne capsules must be prepared and ingested as follows, based on official prescribing information:

  1. Swallow Whole: The capsule should be swallowed whole using liquid. The capsule must not be crushed, chewed, or divided.
  2. Alternative Method: If swallowing the capsule whole is not feasible, the capsule may be opened, and its contents (beads) can be sprinkled onto a small amount of applesauce.
  3. Immediate Intake: The applesauce mixture must be administered immediately and not stored for later use. This should be followed by drinking fluids.

Missed Dose

If a dose of Metadyne is missed, official instructions specify that the medicine should be taken as soon as possible. However, if it is already late in the day, the patient should skip the missed dose and resume the regular schedule the following morning. Do not take two doses at the same time to make up for a missed dose.


Recent Clinical Evidence

Metadyne: Recent Clinical Evidence

This section summarizes key research that has investigated the compound, Metadyne. It serves to describe the scope of the studies, not to provide medical advice, clinical interpretation, or recommendations about treatment.


Clinical Efficacy in Liver Function

Research investigated the link between Metadyne and liver function measures in individuals with chronic liver disease. The evidence described what studies evaluated, not any definitive therapeutic outcomes.

  • Studies evaluated whether Metadyne had an effect on inflammation markers over a 30-day period. Findings from a Phase 2 trial described a shift in data points for certain inflammatory proteins.
  • Another investigation examined the levels of liver enzymes (ALT and AST) following a six-month course of the compound. The study reported that enzyme levels in the treatment group differed from those in the placebo group.
  • Studies evaluated the pharmacokinetics of Metadyne under various administration conditions.

Effects on Fibrosis and Symptom Severity

Research examined parameters related to the progression of liver fibrosis. The studies compared various treatment methods and their effects on non-invasive markers (e.g., Fib-4 score).

  • One investigation compared combination therapy with monotherapy regarding changes in fibrosis over one year. The study did not find a significant difference in the long-term changes between the two groups.
  • The research explored data on symptom severity, as reported by participants using a standardized symptom questionnaire.

Long-Term Safety and Tolerability

Long-term studies have investigated the tolerability and side effects of Metadyne over multiple years.

  • Adverse events reported during a two-year extension trial were reported as being mild to moderate in severity. The most frequently reported events included headache, nausea, and fatigue.
  • The results did not indicate any new signals when comparing the first year of treatment with the subsequent year. Research continues to monitor the compound's long-term effects.

Frequently Asked Questions (FAQ)

Common questions about Metadyne (FAQ)

Q: How quickly should I expect to feel the effects of Metadyne?

A: Metadyne contains an active ingredient that is a rapidly acting germicide, meaning it starts its microbicidal action upon contact. Official data on similar antiseptic products indicate that while the initial microbial reduction is fast, realizing the full antiseptic effect against all target organisms may require up to a few hours.

Q: Does Metadyne start working immediately after the first dose?

A: The active ingredient in Metadyne is designed to begin its microbicidal action upon contact with the skin or wound. However, official product information suggests that achieving the maximal level of efficacy against all target microorganisms may take some time.

Q: Is Metadyne known to cause weight gain?

A: Weight gain is not directly listed as a common side effect of Metadyne. However, the product carries a risk of systemic iodine absorption, especially with prolonged or extensive use, which can lead to abnormal thyroid function, such as hypothyroidism. Symptoms of hypothyroidism can sometimes include changes in energy and weight.

Q: Can Metadyne make you feel drowsy or tired during the day?

A: Official reports from long-term safety studies have noted that fatigue is a reported adverse event when using Metadyne. Regulatory documents do not specifically list drowsiness or somnolence for this type of topical antiseptic product.

Q: What are the most common side effects people report when taking Metadyne?

A: According to official reports, the most frequently observed events when using the topical solution include local irritation, redness, contact dermatitis, headache, nausea, and fatigue. The occurrence of serious systemic effects, such as generalized anaphylactic reactions, is rare.

Q: How long does Metadyne stay in your system after stopping it?

A: Pharmacokinetic studies indicate that if components of the product are absorbed into the bloodstream, they typically have a relatively short half-life of a few hours. Complete clearance of components from the body can depend on individual factors.

Q: Can Metadyne interact negatively with common over-the-counter pain relievers?

A: No known direct interactions have been widely reported between the active ingredient in Metadyne and common over-the-counter pain relievers like acetaminophen or ibuprofen. It is generally advised to inform a healthcare professional about all medications and products being used.

Q: Is it safe to drink coffee or caffeine while on Metadyne?

A: Official regulatory information does not list caffeine or coffee as a specific food or beverage interaction with Metadyne. The documented interactions primarily involve other antiseptic products, certain chemical compounds, and and medications like Lithium.

Q: Are there any specific foods I should avoid while taking Metadyne?

A: No specific food restrictions are typically listed in the official product information for Metadyne. The focus of warnings and interactions is on chemical incompatibilities and drug-drug interactions.

Q: Why do some people say they feel 'fuzzy' or 'foggy' on Metadyne?

A: Feeling 'fuzzy' or 'foggy' is not listed as a standard or common side effect. This product has a risk of systemic iodine toxicity if used extensively or for too long. High systemic iodine levels can potentially lead to general systemic effects like confusion or lethargy.

Q: Is it normal to experience mild headaches when starting Metadyne?

A: Headache is listed in official documents as a frequently observed adverse event in clinical studies. However, official information does not specify if this is more common upon starting treatment or if it tends to subside with continued use.

Q: What happens if you miss a dose of Metadyne?

A: For the topical solution, it should be applied as soon as it is remembered. For the oral capsule formulation, official instructions address missed doses by advising when to skip the dose and resume the normal schedule the following morning.

Q: Can Metadyne be used to treat conditions other than its main use?

A: Regulatory approval limits the official indications for Metadyne to skin disinfection, infection prevention, and wound care. Use for any other condition is not included in the official labeling.

Q: What should I do if a side effect from Metadyne seems concerning but isn't severe?

A: Regulatory guidance suggests discussing less serious side effects that cause concern with a healthcare professional, such as a doctor or pharmacist. If a severe or potentially life-threatening reaction occurs, such as swelling or difficulty breathing, immediate emergency medical attention is necessary.

Q: Can taking Metadyne make you sensitive to sunlight?

A: Increased sensitivity to sunlight, known as photosensitivity, is not explicitly listed among the officially documented skin adverse reactions for Metadyne. The listed skin reactions primarily include local irritation, redness, and contact dermatitis.

Q: Is there a 'withdrawal' period when stopping Metadyne?

A: Official product information does not list specific withdrawal symptoms or a defined withdrawal period upon the discontinuation of Metadyne. Discontinuation of the oral capsule should be done under the guidance of a doctor.

Q: Can Metadyne be taken with blood pressure medication?

A: Official drug interaction data generally does not show a direct interaction between Metadyne's active ingredient and common blood pressure medications. Review of all current medications by a healthcare professional is generally recommended, as systemic interactions are known to occur with medications like Lithium.

Q: Does Metadyne require a special diet?

A: Official regulatory documents do not specify a special diet or major dietary restrictions that are required for the safe use of Metadyne.

Q: Are there any known interactions between Metadyne and herbal supplements like St. John's Wort?

A: Interactions with specific herbal supplements are not universally documented in official labeling. Patients are generally advised to inform a healthcare provider of all herbal products and supplements they are using.

Q: Can Metadyne cause mood swings or irritability?

A: Mood swings and irritability are not listed as direct, common side effects of Metadyne. However, since the product carries a risk of affecting thyroid function, and thyroid disorders can cause changes in mood, this should be noted.

Q: Is it okay to drive or operate machinery while taking Metadyne?

A: If systemic effects occur, such as confusion from iodine absorption, fatigue, or blurred vision, official patient information recommends avoiding driving or operating machinery until these effects have completely resolved.

Q: Does Metadyne cause dry mouth?

A: Dry mouth is not listed as a common adverse event in the regulatory documents for Metadyne. While rare, it has been cited as a potential symptom of severe systemic conditions like kidney failure, which have been reported with excessive use.

Q: Can Metadyne make existing anxiety worse?

A: There is no direct listing of anxiety worsening as a side effect. However, the known risk of abnormal thyroid function due to iodine absorption is a factor, as thyroid disorders can potentially exacerbate pre-existing psychological or emotional conditions.

Q: What should be done if Metadyne causes an upset stomach?

A: Upset stomach is not a common side effect of the topical solution. If this symptom is severe, it may suggest accidental ingestion or overdose, which, according to official warnings, requires immediate medical attention.

Q: Can Metadyne affect sleep patterns or cause insomnia?

A: Official regulatory documents and safety reports do not list insomnia or general sleep pattern changes among the commonly reported side effects of Metadyne.

Q: How often is Metadyne typically taken per day?

A: The oral capsule form of Metadyne is generally prescribed to be taken once daily. The topical solution is typically used on an as-needed basis, or according to the specific application protocol provided by a healthcare professional.

Q: Is Metadyne addictive or habit-forming?

A: The active ingredient in Metadyne is an antiseptic, Povidone-Iodine, which is not classified as an addictive or habit-forming controlled substance according to regulatory authorities.

Q: Are there specific symptoms that mean Metadyne is definitely not for me?

A: Official regulatory information lists strict contraindications for the product. It must not be used if you have a known hypersensitivity to any of its components, have overt hyperthyroidism, or are undergoing radioactive iodine therapy.

Q: Does Metadyne have a strong taste or smell?

A: Official product information does not usually specify the taste. For the topical product, chemical safety data generally indicates it has a characteristic odor or is odorless, depending on the specific formulation.

Q: What kind of specialist usually prescribes Metadyne?

A: The active component, Povidone-Iodine, is widely available over-the-counter as a topical antiseptic and does not require a prescription. However, the oral capsule formulation must be prescribed by a licensed healthcare professional.

Q: Is Metadyne a new drug, or has it been around for a while?

A: The active component of Metadyne, Povidone-Iodine, is an established product. It has been available for many decades and is included on the World Health Organization's List of Essential Medicines.

Q: Why do some people need to take Metadyne for a long time?

A: Official regulatory documents generally advise against prolonged application, defining it as use typically exceeding 14 days, to prevent excessive systemic absorption of iodine. Long-term treatment is restricted due to safety concerns.

Q: Is Metadyne often prescribed in combination with other drugs?

A: Metadyne is typically used alone. Official warnings list specific substances, such as mercury derivatives and certain other antiseptics, that must not be combined with Povidone-Iodine due to chemical incompatibility.

Q: Does Metadyne have any known interactions with grapefruit juice?

A: Official regulatory documents detailing drug and food interactions do not list grapefruit juice as having a known interaction with the active ingredient in Metadyne.

How should Metadyne be stored and disposed of?

Official Storage and Disposal Instructions

Metadyne (Povidone-Iodine) must be stored strictly according to the conditions defined in official regulatory labeling to ensure product stability and prevent misuse.

Storage Requirement Official Guidance
Temperature Store at Controlled Room Temperature (15 C to 30 C / 59 F to 86 F).
Protection Protect from light; do not freeze or expose to excessive heat.
Container Keep in the original container with the cap tightly closed when not in use.
Child Safety Keep out of the reach of children.

Disposal of unused or expired Metadyne must adhere to mandatory guidelines. The product should be disposed of via a medication take-back program or according to state and local regulations for non-wastewater disposal. Single-use items must be discarded immediately after a single application.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Metadyne found in:

A-Z Index: